![]() |
||||
|
|
||||
|
|
||||
Natural Therapy] NEWS: INS-1From: chris (anonymous@obgyn.net)Fri, 26 Jan 2001 13:22:31 +0800
> >INS-1 LOOKS VERY PROMISING IN PHASE II TRIALS > >(MEDSCAPE, JANUARY 16, 2001) - Full analysis of a phase II clinical >trial shows that an experimental thiazolidinedione, INS-1, shows >promise for the treatment of type 2 diabetes, especially in patients >with milder disease. > >Insmed, Inc. is developing the drug, currently called INS-1, for >treatment of type 2 diabetes and polycystic ovary syndrome. INS-1 >acts by replacing the molecule d-chiro-inositol, a mediator of >insulin signaling, thereby sensitizing cells to insulin action. > >"Clearly, we are very pleased with the outcome of this clinical >study, " said Dr. Geoffrey Allan, CEO and president of Insmed, Inc. >"We would expect to have phase III trials completed and a New Drug >Application to the US Food and Drug Administration submitted in the >year 2004." > >For the Full Press Release text, log on to Medscape and this URL >(must have a free Medscape login & password): > >http://diabetes.medscape.com/32177.rhtml?srcmp=endo-011201 > >~~~~~~~~~~~~~~~~~~ >Director of Media Relations >Polycystic Ovarian Support Association, Inc. (PCOSA) >pr@pcosupport.org _________________________________________________________________________ Get Your Private, Free E-mail from MSN Hotmail at http://www.hotmail.com. -- _________________________________________________________________________
|
|
Return to ![]()
Technical Problems: webmaster@obgyn.net
Last Updated: Mon May 19 16:55:44 2008
Women's Insurance Checklist from Auto Insurance Quote
home | medical professionals | women | industry | forums | international